Abstract: This article explores the imperative role of responsible innovation (RI) in guiding the development and integration of emerging technologies within society. With technological progress ...

Abstract: As consensus across the various published AI ethics principles is approached, a gap remains between high-level principles and practical techniques that can be readily adopted to design and ...

The principles, issued on Wednesday, offer broad guidance on how AI should be ‌used to ‌generate and monitor evidence across a drug's lifecycle, from early research and clinical ‌trials to ...

After several months of collaboration, the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released a common set of 10 guiding principles to inform, enhance, and ...

Jan 14 (Reuters) - The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible use of artificial intelligence in developing medicines, ...

US, European Regulators Set Principles for 'Good AI Practice' in Drug Development Jan 14 (Reuters) - The U.S. Food and ‌Drug Administration and the European ‌Medicines Agency jointly issued principles ...

The paper synthesizes global experiences and key lessons in the regulation and supervision of cyber risk in the financial sector. It draws on the IMF’s financial stability surveillance and technical ...

Developed by experts from academia and industry, with specialties in such areas as chemical sciences, pollution prevention, and laboratory safety, Prudent Practices in the Laboratory provides guidance ...

The Advanced Practice Provider (APP) Leadership Advisory Group began as a grassroots conversation — APPs and AHA representatives recognizing that traditional physician and nurse leadership models ...

Regulatory agencies impose stringent legislation and guidelines in the pharmaceutical industry to ensure the safety and quality of medicinal products. While most regulatory research focuses on market ...

The ACC/AHA guideline development process entails a rigorous approach that includes: 1) identifying and defining the scope of clinical topics; 2) reviewing and conducting ongoing surveillance of the ...

NFL Chief Medical Officer Dr. Allen Sills spoke with Biocore's Dr. Ann Good about what goes into the NFL-NFLPA's annual helmet laboratory testing, the rate of improvement we've seen in helmet ...